Most recently, in a prospective study of 80 HCC patients, a multimarker assay combining cell surface markers EpCAM, ASGPR and GPC3 was able to detect HCC CTCs in 97% of the patients with high accuracy. Here, ASGR1 is linked to hepatocellular carcinoma.